). An interval of <3 months between the second and third angioplasty was strongly associated (P<.005) with the occurrence of further restenosis after a third procedure.
Conclusions. The angiographic probability of further restenosis after three successive angioplasty procedures at the same site is similar to that reported after a first angioplasty procedure in studies that used a similar definition of restenosis. Patients who undergo a third angioplasty procedure within 3 months of a previous procedure at the same site have a much higher risk of subsequent restenosis. This easily identified subgroup may benefit from an alternative therapeutic approach. (Circulation. 1993; 88:969-974.) KEY WORDs * angioplasty * restenosis * vessels * circulation T he occurrence of restenosis after initially successful percutaneous transluminal coronary angioplasty has assumed increasing importance as the number of angioplasty procedures performed has increased and the indications for the procedure have become more liberal. Repeat coronary angioplasty is frequently performed for a first restenosis. A repeat procedure appears to have a lower periprocedural risk than a first procedure; the risk of restenosis is comparable to that of a first procedure. [1] [2] [3] [4] [5] [6] The management of patients who go on to develop a second restenosis is problematic. Some studies have suggested that successive angioplasty procedures at the same site are associated with an increasing probability of restenosis7,8 and that very short time intervals between previous restenoses are predictive of future restenoses.7 Most of these studies had very high rates of clinical follow-up: in addition, many patients who did not undergo angiographic follow-up underwent noninvasive evaluation such as exercise testing. However, although the rate of angiographic follow-up in symptomatic patients was high in most studies, the overall rates of angiographic follow-up were much lower. Consequently, although these studies provided valuable information concerning the role of repeat angioplasty procedures in the management of patients with recurrent symptoms after angioplasty, they were not able to provide an accurate estimate of the overall angiographic probability of restenosis associated with the performance of repeated procedures.
No study has examined, by quantitative coronary angiography, the angiographic rate of restenosis when a third angioplasty procedure is performed because restenosis has occurred at a site that was successfully dilated on two previous occasions. We studied the procedural outcome and the angiographic rate of restenosis assessed by quantitative coronary angiography in consecutive patients who underwent such a procedure in our institution, at which we recommend angiographic follow-up to all patients who undergo successful coronary angioplasty. 
Repeat Angioplasty Procedure
Because we perform systematic follow-up angiography after coronary angioplasty, the decision to perform a repeat procedure is generally made at the time of repeat angiography by the operator in consultation with a second cardiologist and after consultation with the patient. Before follow-up angiography, informed consent for the procedure is obtained, and it is explained to the patient that if a repeat procedure is judged necessary, it will be performed immediately after the diagnostic procedure. The decision to perform a repeat angioplasty is based on an evaluation of the anatomic findings at follow-up angiography in conjunction with the results of exercise testing in the context of the patient's current symptoms. The most common reasons for repeat angioplasty are recurrence of symptoms and/or positive results on exercise testing that are considered to be attributable to the restenotic lesion.
Angioplasty was performed according to the standard technique in our laboratory, as previously described. 6 The procedure was considered successful when the residual luminal narrowing in the dilated segment immediately after angioplasty was estimated visually to be <50% and when no major complication (ECG or enzymatic evidence of myocardial infarction, the need for bypass surgery during hospitalization, or in-hospital death) occurred. Procedural success, as defined above, was achieved in 98 of the 99 patients. In two procedures that were judged by the operator to be successful, the residual stenosis was subsequently shown by quantitative angiography to be >50%. These two procedures were classified as uncomplicated failures. Restenosis was defined by quantitative coronary angiography as the recurrence of >50% luminal narrowing in a segment that had previously been dilated to <50%.
Angiography was performed in at least two projections, after the intracoronary injection of isosorbide dinitrate (2 mg), just before and immediately after angioplasty. These projections were recorded in our data base, and the follow-up angiogram was performed, after the intracoronary injection of isosorbide dinitrate, in the same projections.
Quantitative Angiographic Analysis
Quantitative computer-assisted angiographic measurements and a qualitative assessment of the characteristics of the dilated lesion were performed on angiograms obtained before and immediately after angioplasty and at 6-month follow-up. Measurements were performed on end-diastolic frames from angiograms obtained 2 minutes after the intracoronary administration of isosorbide dinitrate (2 mg) with the computer-assisted evaluation of stenosis and restenosis (CAESAR) system we have developed and validated in conjunction with the Bioengineering Department of the University of Lille. The cine film was projected with a 35AX projector (Tagarno, Denmark), and the cine frame selected for analysis was scanned with a high-resolution CCD video camera (JVC). The signal produced by the video camera was digitized in a matrix size of 1024x768 pixels with 9 bits brightness resolution and displayed on a video monitor. User interaction was possible by means of a writing tablet. Centerlines were traced manually for a proximal reference segment, for a distal reference segment, and for the stenotic segment. The contours were subsequently detected automatically on the basis of the weighted sum of first and second derivative functions applied to the digitized brightness information. We had previously determined the accuracy (defined as the absolute difference between the measured and true value) and the precision (defined as the SD of these differences) of the system according to the recommendations of Herrington et a19 in a study analyzing cine films of Plexiglas blocks containing precision-drilled models (1 through 5.15 mm in diameter) of coronary arteries ifilled with different concentrations of contrast medium.
The mean accuracy was 0.07 mm; the precision was 0.14 mm. The interobserver and intraobserver variation of measurements obtained under routine clinical conditions were also previously reported.10 The mean intraobserver variation, expressed as the standard error of the estimate (SEE), was 0.10 mm. The interobserver variation (SEE) was 0.11 mm. quently underwent follow-up angiography, 42 were asymptomatic at the time of follow-up angiography. The mean time to follow-up angiography in this group was 7.2±1.7 months. Of these 42, 19 had positive results on exercise testing, 14 had negative results on exercise testing, and 9 did not have exercise tests.
Of the 83 patients who had a successful third procedure and who subsequently underwent follow-up angiography, 31 had stable angina pectoris at the time of follow-up angiography. The mean time to follow-up angiography in this group was 5.9±1.9 months. Of these 31, 25 had positive results on exercise testing, 3 had negative results on exercise testing, and 3 did not have exercise tests.
Of the 83 patients who had a successful third procedure and who subsequently underwent follow-up angiography, 10 had unstable angina pectoris at the time of follow-up angiography. The mean time to follow-up angiography in this group was 4.8±2.6 months. None underwent exercise testing.
Restenosis (recurrence of .50% stenosis at the dilated site determined by quantitative coronary angiography) occurred in 32 patients (39%). Patients Without Angiographic Follow-up Clinical follow-up was available for 11 of the 13 patients with initially successful procedures who did not undergo repeat angiography. One patient who had undergone successful dilation of an isolated left anterior descending coronary artery stenosis underwent coronary artery bypass surgery 3 months later because he developed unstable angina. He did not undergo repeat angiography before surgery. One patient had a non-Qwave myocardial infarction 1 month after successful angioplasty. He did not undergo repeat angiography. Of the remaining 11 patients, 9 were asymptomatic at the time of scheduled angiographic follow-up. Of these 9 patients, 6 underwent noninvasive tests at the time of scheduled angiographic follow-up. Of these 6, 4 underwent exercise tests; 2 were positive and 2 were negative; and the other 2 underwent exercise thallium scintigraphy with negative results in both patients.
Predictors of a Third Restenosis
We determined whether clinical, anatomic, or procedural variables were associated with recurrent restenosis ( The major finding of this study is that the angiographic probability of restenosis, defined as the recurrence of >50% luminal narrowing at the dilated site determined by quantitative coronary angiography, when a third angioplasty procedure is performed at a site that has undergone restenosis after two pre.ious angioplasty procedures is similar to the probability of restenosis after a first angioplasty procedure in our institution and in recent clinical trials that used similar objective investigator-independent criteria to define restenosis. 13 In addition, this study extends previous observations that demonstrated higher rates of restenosis in patients in whom a repeat angioplasty procedure for restenosis is undertaken soon after an initial procedure. Various rates of restenosis have been reported after a first angioplasty procedure. The reasons for this disparity between studies is undoubtedly multifactorial. Differences between groups in the distribution of known risk factors for restenosis, such as unstable angina or diabetes mellitus, may in part account for these differences. Differences in rates of follow-up angiography and in the methods used to determine the probability of restenosis in patients who did not undergo follow-up angiography could also contribute. In addition, angiographic definitions of restenosis vary between studies, and even when studies use the same angiographic criterion for restenosis, they may use differing techniques, with various degrees of objectivity, to assess the follow-up angiograms.
In our institution, we recommend angiographic follow-up to all patients who have successfully undergone angioplasty. The overall rate of follow-up angiography, 86%, in the consecutive patient population reported here is similar to our overall rate of angiographic follow-up. 6 The follow-up angiograms were analyzed by quantitative coronary angiography by independent observers. Thus, the results reflect, with reasonable accuracy, the true angiographic probability of restenosis, defined by the recurrence of a .50% stenosis, in our patient population.
We observed a rate of restenosis of 39%; this rate is similar to the 43% and 40% rates that were encountered during the same time period in our institution after a first14 or second angioplasty procedure.6 This rate is similar to the 43% rate of restenosis in a recent large clinical trial that examined the effect of corticosteroids on restenosis'3 and to the rate of restenosis after balloon angioplasty in another recent study that compared restenosis rates after balloon angioplasty with those after atherectomy and that used the same angiographic definition of restenosis. 15 It has been suggested that the restenosis rate is higher after a third than after a first or second angioplasty7,8,16; our results do not support this suggestion. In the largest such reported study, Teirstein et a17 found a clinical restenosis rate of 43% in 74 patients who underwent a third angioplasty for a second restenosis at the same site. In that study, the rate of follow-up angiography in symptomatic patients was very high; however, asymptomatic patients rarely underwent follow-up angiography. Consequently, the probability of restenosis in asymptomatic patients was assessed from clinical data and the results of noninvasive tests. The restenosis rate after a third angioplasty at the same site was higher than that reported from the same institution after an initial angioplasty (31%) or after angioplasty for a first restenosis (37%).
Glazier et a18 reported a rate of 20% restenosis after a first angioplasty, 26% after a second, and 34% after a third angioplasty. In their study, restenosis was defined by the recurrence of angina with angiographic documentation of >50% stenosis at the site of a previous dilation. In their institution, the policy was to recommend follow-up angiography after angioplasty only to patients who developed symptoms or signs of recurrent ischemia.
The explanation for the discrepancy between the results of these and other similar studies and the results of the present study may be related to the low rate of angiographic follow-up in asymptomatic patients in most reported studies ( In contrast, the 20% and 31% rates of restenosis after a first angioplasty are significantly lower than the restenosis rates that were reported after a first angioplasty in recent randomized trials using quantitative coronary angiography and systematic angiographic follow-up,13 which are comparable to the 43% rate of restenosis after a first procedure in our institution.1
Predictors of Further Restenosis
An interval of <3 months from the second to the third procedure was found to be associated with further restenosis after a third procedure. We and others have previously shown the importance of a short interval between an initial angioplasty procedure and a first repeat procedure as a determinant of the risk of further restenosis.24, 6 Teirstein et a17 found, in patients undergoing a third angioplasty at the site of two previous procedures, that the rate of restenosis in patients for whom the intervals between the first and second and the second and third procedures were <3 months was twice as high as that in the group in whom either of these intervals was >3 months. We found that the time interval between successive procedures was the only determinant of the risk of further restenosis in patients after multiple repeat procedures. When the interval between the first and second repeat procedures was <3 months, the restenosis rate was 71%, whereas when the interval was >3 months, the restenosis rate was 30%. This is in agreement with a recent study that reported that the only predictor of a second restenosis was a shorter time interval between the first and second balloon angioplasty procedures in those patients who subsequently required a third angioplasty procedure.'6 Interestingly, the importance of the time interval between procedures is not peculiar to balloon angioplasty; a recent study showed that a similar phenomenon is observed when directional atherectomy is performed in patients who have developed restenosis after balloon angioplasty.12 The reasons why a short time interval between procedures is associated with an enhanced risk of further restenosis remain unclear. Two possible explanations have been proposed: it may be that the time at which the repeat angioplasty is performed is merely an indication of the patient's tendency to develop restenosis; alternatively, it may be that the timing of the repeat angioplasty is itself responsible for the enhanced risk of restenosis. A recent experimental study supports the second hypothesis; the degree of neointimal hyperplasia when two successive angioplasty procedures were performed in normal pig coronary arteries was inversely related to the time interval between the two procedures.19
Study Limitations
This was a retrospective study. However, the patients were a consecutive group that underwent the third angioplasty procedure in an institution in which the probability that a patient undergoes follow-up angiography is less dependent on symptomatic status after angioplasty. The high rate of angiographic follow-up coupled with the use of quantitative coronary angiography to assess the angiographic outcome allowed an objective assessment of the angiographic probability of restenosis. Furthermore, the predominance of patients with single-vessel disease and recurrence of angina after the previous procedure reflects a problem likely to be encountered with increasing frequency as a consequence of the increasing use of angioplasty as an alternative to medical treatment in patients with singlevessel disease.20
Clinical Implications
The management of patients with a second restenosis is a difficult issue. Patient or physician preference for a particular form of treatment and financial considerations may all play a role in the decision to perform a further intervention (ie, bypass surgery or another angioplasty procedure) or to opt for medical therapy. A major consideration in the decision to perform another angioplasty procedure is the likelihood of a long-term successful outcome. Contrary to the conclusions of some previous studies, our results demonstrate that the overall angiographic probability of further restenosis is not increased in this group of patients. Furthermore, the higher procedural success rate and lower complication rate (compared with a first angioplasty procedure) previously documented in many studies of a first repeat angioplasty also seem to apply to a second repeat procedure.21 Finally, the importance of the time interval between successive angioplasty procedures as a determinant of the risk of further restenosis previously documented by ourselves and others for a first repeat procedure is equally marked in these patients.
Our results suggest that a second repeat procedure can be performed with the same procedural risk as a first repeat procedure; the global risk of further restenosis is the same as after a first repeat procedure. However, there is an easily identified subgroup of patients (those in whom the second repeat procedure is performed within 3 months of the first) in whom a further repeat procedure is associated with a high risk of further restenosis and in whom an alternative therapeutic approach may be preferable.
